Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alteration in flow delivery with antisyphon devices.

C McCarroll1, D McAtamney, R Taylor

  • 1Royal Belfast Hospital for Sick Children, 180 Falls Road, Belfast BT12 6BE, UK.

Anaesthesia
|April 26, 2000
PubMed
Summary

Antisyphon devices in syringe driver infusions significantly delay initial flow, especially at lower rates. Clinicians should be aware of this start-up time to ensure timely medication delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intravenous extension lines and the potential for residual drug administration.

Anaesthesia·2014
Same author

Epidural blood patch for hypoactive-hypoalert behaviour secondary to spontaneous intracranial hypotension.

British journal of anaesthesia·2010
Same author

Prilocaine induced methaemoglobinaemia in a medically compromised patient. Was this an inevitable consequence of the dose administered?

British dental journal·2007
Same author

Combined spinal-epidural anaesthesia for caesarean section in a patient with long QT syndrome.

International journal of obstetric anesthesia·2007
Same author

Who or what defines a patient's best interests?

Anaesthesia·2007
Same author

Who or what defines 'best interests'?

Anaesthesia·2006

Area of Science:

  • Medical Devices
  • Pharmacology
  • Clinical Engineering

Background:

  • Syringe drivers are commonly used for medication delivery.
  • Antisyphon devices are incorporated into some infusion sets to prevent backflow.
  • The impact of these devices on infusion start-up time is not well-established.

Purpose of the Study:

  • To evaluate the effect of antisyphon devices on the time to initial flow from syringe drivers.
  • To compare the start-up time of infusion sets with different antisyphon devices against a control.

Main Methods:

  • Tested antisyphon devices from B Braun, Wescott, and Vygon.
  • Integrated devices between a 50-ml syringe and extension set, primed with saline.
  • Measured start-up time in four identical syringe drivers at 2, 10, and 50 ml/h, repeated 15 times each.

Main Results:

  • At 2 ml/h, all antisyphon devices significantly increased start-up time compared to the control (p < 0.0001).
  • The delay in initial flow was less pronounced at higher infusion rates (10 and 50 ml/h).
  • Variability in start-up times was observed across different antisyphon device manufacturers.

Conclusions:

  • Antisyphon devices can introduce a clinically relevant delay in the onset of infusion from syringe drivers, particularly at low flow rates.
  • Healthcare professionals must recognize this delay to prevent potential under-infusion or delayed therapy.
  • Further investigation into optimizing antisyphon device design or alternative strategies to mitigate start-up delays is warranted.

Related Experiment Videos